Abstract:The Varicella Zoster Virus (VZV) is a ubiquitous human alpha-herpesvirus that is the causative agent of chicken pox and shingles. Although an attenuated VZV vaccine (v-Oka) has been widely used in children in the United States, chicken pox outbreaks are still seen, and the shingles vaccine only reduces the risk of shingles by 50%. Therefore, VZV still remains an important public health concern. Knowledge of VZV replication and pathogenesis remains limited due to its highly cell-associated nature in cultured cells, the difficulty of generating recombinant viruses, and VZV's almost exclusive tropism for human cells and tissues. In order to circumvent these hurdles, we cloned the entire VZV (p-Oka) genome into a bacterial artificial chromosome that included a dual-reporter system (GFP and luciferase reporter genes). We used PCR-based mutagenesis and the homologous recombination system in the E. coli to individually delete each of the genome's 70 unique ORFs. The collection of viral mutants obtained was systematically examined both in MeWo cells and in cultured human fetal skin organ samples. We use our genome-wide deletion library to provide novel functional annotations to 51% of the VZV proteome. We found 44 out of 70 VZV ORFs to be essential for viral replication. Among the 26 non-essential ORF deletion mutants, eight have discernable growth defects in MeWo. Interestingly, four ORFs were found to be required for viral replication in skin organ cultures, but not in MeWo cells, suggesting their potential roles as skin tropism factors. One of the genes (ORF7) has never been described as a skin tropic factor. The global profiling of the VZV genome gives further insights into the replication and pathogenesis of this virus, which can lead to improved prevention and therapy of chicken pox and shingles.

Insights into the function of tegument proteins from the varicella zoster virus

Molecular studies of Varicella zoster virus

Manipulation of the Innate Immune Response by Varicella Zoster Virus

Molecular Aspects of Varicella-Zoster Virus Latency

Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis

Structure–function analysis of varicella-zoster virus glycoprotein H identifies domain-specific roles for fusion and skin tropism

Modulation of Host CD59 Expression by Varicella-Zoster Virus in Human Xenografts in Vivo.

Clinical Features of Varicella-Zoster Virus Infection

Structures of the Varicella Zoster Virus Glycoprotein E and Epitope Mapping of Vaccine-Elicited Antibodies

ORF7 of Varicella-Zoster Virus is a Neurotropic Factor

Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids

The precise function of alphaherpesvirus tegument proteins and their interactions during the viral life cycle

Construction of a pathological model of skin lesions in acute herpes zoster virus infection and its molecular mechanism

Preparation of Monoclonal Antibodies against Glycoprotein N of Varicella-zoster Virus and a Preliminary Study

Glycoprotein E-Displaying Nanoparticles Induce Robust Neutralizing Antibodies and T-Cell Response against Varicella Zoster Virus

Innate immune evasion of alphaherpesvirus tegument proteins

Varicella Zoster Virus (VZV) Infection: A Comprehensive Review of Chickenpox

Research Progress on Anti-Varicella-zoster Virus Agents

Efficacy of varicella (VZV) vaccination: an update for the clinician

Genome-Wide Mutagenesis Reveals That ORF7 is a Novel VZV Skin-Tropic Factor

Insights into varicella-zoster virus assembly from the B- and C-capsid at near-atomic resolution structures